Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 11454878

Recurrent epithelial ovarian carcinoma: a randomized phase III study of pegylated liposomal doxorubicin versus topotecan.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2001 Jul 15
First author
Gordon AN

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Gordon AN
      type
      Author
    2. name
      Fleagle JT
      type
      Author
    3. name
      Guthrie D
      type
      Author
    4. name
      Parkin DE
      type
      Author
    5. name
      Gore ME
      type
      Author
    6. name
      Lacave AJ
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Gordon AN
      type
      Author
    2. name
      Fleagle JT
      type
      Author
    3. name
      Guthrie D
      type
      Author
    4. name
      Parkin DE
      type
      Author
    5. name
      Gore ME
      type
      Author
    6. name
      Lacave AJ
      type
      Author
    bibliography ids
    1. nci-bib-2243e9a5b1813a6f40644171
    book metadata
    content sha256
    0ad1c111324b9d2f11f1002832b9a86e6ad0c302e9dbe1631924b63a62846872
    document type
    citation
    dois
    1. 10.1200/JCO.2001.19.14.3312
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:11454878
    immutable id
    pubmed:11454878@0ad1c111324b9d2f11f1002832b9a86e6ad0c302e9dbe1631924b63a62846872
    journal
    abbreviation
    J Clin Oncol
    issn electronic
    Source null
    issn print
    0732-183X
    issue
    14
    name
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    nlm unique id
    8309333
    pages
    3312-22
    volume
    19
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      11454878
      provenance
      batch id
      bc1299bcdb6a81bdf655
      provider
      NCBI PubMed ESummary
      record sha256
      17f8aadfc1c504a58c2b4d8719b68d869c3cece224b2388fd9bd3141301df3cf
      response sha256
      c4d63e9a162706394efcc7d20cd416503379c383137f167684654db2709afc4f
      retrieved at
      2026-09-09T23:45:42.126507+00:00
      publication date
      display
      2001 Jul 15
      precision
      day
      year
      2001
      publication types
      1. Clinical Trial
      2. Clinical Trial, Phase III
      3. Comparative Study
      4. Journal Article
      5. Multicenter Study
      6. Randomized Controlled Trial
      7. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/11454878/
      title
      Recurrent epithelial ovarian carcinoma: a randomized phase III study of pegylated liposomal doxorubicin versus topotecan.

      Preserved source evidence · Not medical advice